Literature DB >> 10782464

Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung.

T Iwamasa1, J Miyagi, K Tsuhako, T Kinjo, Y Kamada, T Hirayasu, K Genka.   

Abstract

On the subtropical island of Okinawa, squamous cell carcinoma (SCC), particularly the well-differentiated form, is the most frequent type of lung cancer, while this form is relatively rare on the Japanese mainland and in other countries. Furthermore, in Okinawa, in 1993, 80% of SCC cases of the lung were found to be infected with human papillomavirus (HPV). We studied the prognosis of SCC of the lung with HPV infection (n = 25) and compared it with non-HPV-infected SCC (n = 16). Using the Kaplan-Meier method (Wilcoxon analysis), the prognosis of HPV-infected cases was found to be better than that of the non-infected cases. In the virus-infected cases, apoptosis and infiltration of a large number of Langerhans cells were demonstrated. In addition to these findings, the virus-infected tumors were demonstrated to be histologically well-differentiated, perhaps contributing to the favorable prognosis. However, among the virus-infected cases, the type 16 virus-infected cases showed a poorer prognosis, compared to those infected with other HPV types. p53 gene mutation was also examined, and was considered to be an unfavorable prognostic factor, as reported elsewhere. However, in Okinawa, HPV-positive cases with p53 mutations showed a slightly better prognosis than did non-viral infected cases with p53 mutations. The TNM staging system was also useful for categorizing the virus-infected cases. The prognosis of stage III (A and B) cases was poor. All of our present cases received surgical treatment. Chemotherapy and radiation therapy were not performed. Such treatment, however, might be effective, because virus-infected uterine cervical carcinomas have been routinely treated with chemotherapy and radiation. Furthermore, if the immunological basis of increased Langerhans cell infiltration in HPV-infected cases is elucidated, a clinical trial with immunotherapy may be favorable for the clinical outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10782464     DOI: 10.1016/S0344-0338(00)80069-2

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

Review 1.  HPV infections and lung cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  HPV-associated lung cancers: an international pooled analysis.

Authors:  Camille Ragin; Monisola Obikoya-Malomo; Sungjin Kim; Zhengjia Chen; Rafael Flores-Obando; Denise Gibbs; Chihaya Koriyama; Francisco Aguayo; Jill Koshiol; Neil E Caporaso; Giovanna E Carpagnano; Marco Ciotti; Hirotoshi Dosaka-Akita; Masashi Fukayama; Akiteru Goto; Demetrios A Spandidos; Vassilis Gorgoulis; Daniëlle A M Heideman; Robert A A van Boerdonk; Kenzo Hiroshima; Reika Iwakawa; Nikolaos G Kastrinakis; Ichiro Kinoshita; Suminori Akiba; Maria T Landi; H Eugene Liu; Jinn-Li Wang; Ranee Mehra; Fadlo R Khuri; Wan-Teck Lim; Taofeek K Owonikoko; Suresh Ramalingam; Emmanuela Sarchianaki; Kari Syrjanen; Ming-Sound Tsao; Jenna Sykes; Siew Wan Hee; Jun Yokota; Apostolos Zaravinos; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2014-02-12       Impact factor: 4.944

3.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

4.  The association between human papillomavirus infection and lung cancer: a system review and meta-analysis.

Authors:  Wei-Min Xiong; Qiu-Ping Xu; Xu Li; Ren-Dong Xiao; Lin Cai; Fei He
Journal:  Oncotarget       Date:  2017-10-09

Review 5.  Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.

Authors:  Lanwei Guo; Shuzheng Liu; Shaokai Zhang; Qiong Chen; Meng Zhang; Peiliang Quan; Xibin Sun
Journal:  Oncotarget       Date:  2017-05-23

6.  Human papillomavirus16 E6 but not E7 upregulates GLUT1 expression in lung cancer cells by upregulating thioredoxin expression.

Authors:  Zi-Yu Gao; Na-Jin Gu; Ming-Zhe Wu; Shi-Yu Wang; Hong-Tao Xu; Qing-Chang Li; Guang-Ping Wu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.